Literature DB >> 18095964

Investigating the pharmacodynamics of ketamine in children.

David W Herd1, Brian J Anderson, Natalie A Keene, Nicholas H G Holford.   

Abstract

BACKGROUND: The aim of this study was to describe ketamine pharmacodynamics (PD) in children. Adult ketamine concentrations during recovery are reported as 0.74 mg.l(-1) (sd 0.24 mg.l(-1)) with an EC(50) for anesthesia of 2 mg.l(-1) (sd 0.5 mg.l(-1)), but pediatric data are few.
METHODS: Children presenting for painful procedures in an Emergency Department were given ketamine 1-1.5 mg.kg(-1) i.v. Blood was assayed for ketamine on three to six occasions (median 3) over the subsequent 14-152 min (median 28.5). Procedures were videotaped. Level of sedation (0-5; unresponsive - spontaneously awake without stimulus) and a test of memory were recorded. PD was investigated using a variable slope E(max) model (sedation) or logistic regression (arousal time, memory) with nonlinear mixed effects models.
RESULTS: In total 60 children were enrolled. Pharmacokinetic data were collected in 54 of these children and there were 43 children available for PD study. The mean age was 8.15 years (sd 3.5 years) and weight was 34.9 kg (sd 15.8 kg). The half-time describing equilibration between the effect compartment and central compartment was 11 s (95% CI 0.07-20 s). The EC(50) for arousal was 0.52 (90% CI 0.22-1.17) mg.l(-1). The E(max) model with a baseline (E(0)) of five (spontaneously awake without stimulus) yielded a fractional E(max) 0.939 [coefficient of variability (CV) 24%], an EC(50) 0.56 (CV 136%) mg.l(-1) and a Hill coefficient 3.71. The EC(50) for recall memory was 0.44 (90% CI 0.09-1.70) mg.l(-1). The EC(50) for remembering was 0.38 (90% CI 0.12-1.75) mg.l(-1).
CONCLUSIONS: Concentrations associated with arousal in children are analogous to adults. The ability to recall and remember occurs at similar concentrations to those associated with arousal. A concentration of 1 mg.l(-1) was associated with a sedation level of three or less (arouses to consciousness with moderate tactile or loud verbal stimulus) in 95% of children while 1.5 mg.l(-1) was associated with a sedation level of two or less (rouses slowly to consciousness with sustained painful stimulus) in 95% of children. These concentrations can be attained for 3-4 min after 1 mg.kg(-1) and 1.5 mg.kg(-1) ketamine IV bolus, respectively. The mean arousal time can be anticipated at approximately 10 min (1 mg.kg(-1)) and 15 min (1.5 mg.kg(-1)).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095964     DOI: 10.1111/j.1460-9592.2007.02384.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  17 in total

Review 1.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

2.  An audit of the use of intravenous ketamine for paediatric dental conscious sedation.

Authors:  M N Wood; M C G Manley; N Bezzina; R Hassan
Journal:  Br Dent J       Date:  2015-05-22       Impact factor: 1.626

3.  Pupillary reflex dilation in response to incremental nociceptive stimuli in patients receiving intravenous ketamine.

Authors:  Nada Sabourdin; Thomas Giral; Risa Wolk; Nicolas Louvet; Isabelle Constant
Journal:  J Clin Monit Comput       Date:  2017-10-17       Impact factor: 2.502

4.  Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration.

Authors:  Ingeborg Noppers; Erik Olofsen; Marieke Niesters; Leon Aarts; René Mooren; Albert Dahan; Evan Kharasch; Elise Sarton
Journal:  Anesthesiology       Date:  2011-06       Impact factor: 7.892

5.  Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers.

Authors:  Erik Olofsen; Ingeborg Noppers; Marieke Niesters; Evan Kharasch; Leon Aarts; Elise Sarton; Albert Dahan
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

Review 6.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

7.  Comparison of TIVA with different combinations of ketamine-propofol mixtures in pediatric patients.

Authors:  Ebru Biricik; Feride Karacaer; Ersel Güleç; Özgür Sürmelioğlu; Murat Ilgınel; Dilek Özcengiz
Journal:  J Anesth       Date:  2017-12-16       Impact factor: 2.078

8.  Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.

Authors:  Christoph P Hornik; Daniel Gonzalez; John van den Anker; Andrew M Atz; Ram Yogev; Brenda B Poindexter; Kee Chong Ng; Paula Delmore; Barrie L Harper; Chiara Melloni; Andrew Lewandowski; Casey Gelber; Michael Cohen-Wolkowiez; Jan Hau Lee
Journal:  J Clin Pharmacol       Date:  2018-04-20       Impact factor: 2.860

9.  Intravenous S-ketamine does not inhibit alveolar fluid clearance in a septic rat model.

Authors:  Christian Fastner; Heimo Mairbäurl; Nina C Weber; Koen van der Sluijs; Florian Hackl; Lorenz Hotz; Albert Dahan; Markus W Hollmann; Marc M Berger
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

10.  An innovative safe anesthesia and analgesia package for emergency pediatric procedures and surgeries when no anesthetist is available.

Authors:  Kevin R Schwartz; Karla Fredricks; Zaid Al Tawil; Taylor Kandler; Stella A Odenyo; Javan Imbamba; Brett D Nelson; Thomas F Burke
Journal:  Int J Emerg Med       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.